Blood Glucose Test Strips Market - Forecasts from 2018 to 2023

Blood Glucose Test Strips Market - Forecasts from 2018 to 2023

The blood glucose test strips is projected to grow at a CAGR of 5.65% to reach US$14.191 billion by 2023, from US$10.204 billion in 2017. Growing prevalence if diabetes around the globe is considered as the key driver for the growth of the blood glucose test strips market as diabetes treatment requires consistent monitoring of the blood glucose levels. According to World Health Organization number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Moreover increasing healthcare expenditure is also considered as the key driver for the growth of the market. APAC region is expected to be the fastest growing region for blood glucose test strips market due to rise in the prevalence of diabetes and increasing awareness about the usage of various devices to test diabetes. 

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Ophthalmic Laser value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the Blood Glucose Test Strips.

Major industry players profiled as part of the report are Medtronic, Johnson & Johnson, AgaMatrix, Inc., Abbott Diabetes Care, Arkray and Roche among others.

Segmentation

The Blood Glucose Test Strips has been analyzed through following segments:

By Diabetes Type

Type I Diabetes

Type II Diabetes

 

By Distribution Channel

Online

Offline

 

By End Users

Hospitals and Clinics

Ambulatory Surgery Centers

Diagnostic Centers

 

By Geography

North America

USA

Canada

Mexico

Others

 

South America

Brazil

Argentina

Others

 

Europe

Germany

France

United Kingdom

Spain

Others

 

Middle East and Africa

Saudi Arabia

United Arab Emirates

Others

 

Asia Pacific

China

Japan

South Korea

India

Others

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. BLOOD GLUCOSE TEST STRIPS BY DIABETES TYPE
5.1. Type I Diabetes
5.2. Type II Diabetes
6. BLOOD GLUCOSE TEST STRIPS BY DISTRIBUTION CHANNEL
6.1. Online
6.2. Offline
7. BLOOD GLUCOSE TEST STRIPS BY END-USER 
7.1. Hospitals and Clinics
7.2. Ambulatory Surgery Centers 
7.3. Diagnostic Centers
8. BLOOD GLUCOSE TEST STRIPS MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. United Arab Emirates
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. South Korea
8.5.4. India
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1.  Market Share Analysis
9.2. Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Medtronic 
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Johnson & Johnson 
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. AgaMatrix, Inc. 
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Abbott Diabetes Care 
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. Arkray 
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. Roche
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. LifeScan
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. Ypsomed Holding AG
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. Sanofi
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. Dexcom
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER 

Medtronic

Johnson & Johnson

AgaMatrix, Inc.

Abbott Diabetes Care

Arkray

Roche

LifeScan

Ypsomed Holding AG

Sanofi

Dexcom


  • SKU:
  • Publishing Date: 2018-10-26
  • Product Code: 1
  • Availability: In Stock
  • $3,950.00
  • Ex Tax: $3,950.00

Available Options